MARKET

RXST

RXST

Rxsight, Inc.
NASDAQ
24.84
-0.06
-0.24%
Pre Market: 25.80 +0.96 +3.86% 04:16 03/24 EDT
OPEN
24.35
PREV CLOSE
24.90
HIGH
24.87
LOW
24.09
VOLUME
1
TURNOVER
0
52 WEEK HIGH
66.54
52 WEEK LOW
24.09
MARKET CAP
1.01B
P/E (TTM)
-35.1642
1D
5D
1M
3M
1Y
5Y
1D
BUZZ-Jefferies starts coverage on Rxsight with 'buy' on growth potential
Reuters · 53m ago
Weekly Report: what happened at RXST last week (0317-0321)?
Weekly Report · 1h ago
RXSIGHT INC <RXST.O>: JEFFERIES INITIATES COVERAGE WITH BUY RATING; PRICE TARGET $50
Reuters · 7h ago
RxSight Is Maintained at Buy by B of A Securities
Dow Jones · 3d ago
RxSight Price Target Cut to $36.00/Share From $60.00 by B of A Securities
Dow Jones · 3d ago
B of A Securities Maintains Buy on RxSight, Lowers Price Target to $36
Benzinga · 3d ago
RxSight price target lowered to $36 from $60 at BofA
TipRanks · 3d ago
RxSight’s Path to Profitability: A Buy Rating Amid Revenue Growth and Operational Leverage
TipRanks · 3d ago
More
About RXST
RxSight, Inc. is a commercial-stage medical technology company, which is engaged in improving the vision of patients following cataract surgery. The Company’s RxSight Light Adjustable Lens system (RxSight system) is a cataract technology that enables doctors to customize and optimize visual acuity for patients after surgery. The RxSight system includes the RxSight Light Adjustable Lens (LAL), the RxSight Light Delivery Device (LDD), and various accessories. Its LAL is an intraocular lens (IOL) made of photosensitive material that changes shape in response to specific patterns of ultraviolet (UV) light generated by its LDD. It designed its RxSight system to address the shortcomings of competitive IOL technologies and provide a solution that doctors can trust to improve visual outcomes. Its RxSight system helps the surgeon perform a standard cataract procedure to implant the LAL and then uses the LDD to modify the lens with the visual correction needed for the patient’s vision outcomes.

Webull offers Rxsight Inc stock information, including NASDAQ: RXST real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RXST stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RXST stock methods without spending real money on the virtual paper trading platform.